Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US11154712B2 · kind B2 · utility
1Cited by
115References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2015 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Jan 3, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are methods, devices and compositions for assessing neuromodulation efficacy based on changes in the level of one or more biomarkers in plasma or urine collected from a human subject following a renal neuromodulation procedure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.